Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.850
-0.090 (-4.64%)
At close: Nov 2, 2026, 4:00 PM EST
1.850
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:10 PM EST
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $46.99 million as of November 2, 2026. It is the 30,145th most valuable company in the world and the 4,618th biggest in the United States. Its market cap has decreased by 10.81% in one year.
Market Cap
46.99M
Enterprise Value
27.72M
1-Year Change
-10.81%
Global Rank
Country Rank
#4,618 United States
Category
ChartMarket Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $46.99M, a decrease of -62.45%. That is a compound annual growth rate of -31.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 46.99M | 130.34% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Connect Biopharma Holdings | 50.52M |
| Hyperion DeFi | 50.04M |
| iBio, Inc. | 49.43M |
| Gain Therapeutics | 49.32M |
| Kalaris Therapeutics | 48.32M |
| Annovis Bio | 48.14M |
| Werewolf Therapeutics | 47.92M |
| LeonaBio | 46.54M |